Transplantation of derivatives of ES cells

Akihiko Numata, Mine Harada

Research output: Contribution to journalReview articlepeer-review

Abstract

Solid organ transplantation and hematopoietic stem cell transplantation always face major obstacles in the scarcity of organs and hematopoietic cells from human donors. Theoretically the establishment of human ES cell lines and multilineage differentiation from human ES cell lines could make transplantation therapy without donors practical. The clinical promise of human ES cell-based therapies is enormous. However, appropriate derivation of human ES cells to functionally matured and differentiated cells has not been established and serious concerns including ethical problems, safety, efficacy and strategy for preventing rejection will need to be addressed before clinical trials can be initiated.

Original languageEnglish
Pages (from-to)425-432
Number of pages8
JournalBiotherapy
Volume16
Issue number5
Publication statusPublished - Sep 2002

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Transplantation of derivatives of ES cells'. Together they form a unique fingerprint.

Cite this